After single oral doses, CBD appeared rapidly in plasma; time to maximum plasma concentration (tmax) was approximately 4–5 h. CBD reached steady state after approximately 2 days, with moderate accumulation (1.8- to 2.6-fold) after 750 and 1500 mg CBD
From the research… ” The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence” characterizes non-prescription CBD products in the United States and EU, as “low daily doses” of <1 mg/kg in capsules containing 10–50 mg CBD. Orally administered oils containing 15–240 mg/ml CBD, are also considered “low dose”.
CBD impacts multiple conditions including Alzheimers, Parkinson’s, M.S., Epilepsy, Pain, Anxiety, Nausea, Depression, Cancer, Inflammatory disease, Rheumatoid arthritis, Infection, Irritable Bowel, Crohn’s disease, Cardiovascular disease and Diabetic complications.
Shopping Cart
Your cart is currently empty.
Enable cookies to use the shopping cart